Mohamed H. Sayegh

发表

The role of B7 and CD2 family costimulatory molecules in natural killer cell function

John P. Forman, Yvette Latchman, Alan D. Salama, 2003 .

a Reciprocal Cytokine Environment In Vivo Defining Th1 and Th2 Immune Responses in

Mohamed H. Sayegh, Samia J. Khoury, Tanuja Chitnis, 2013 .

Chronic renal allograft dysfunction (CAD): new frontiers. Introduction.

Mohamed H. Sayegh, 2010, Kidney international. Supplement.

Expansion and characterization of CD4(+)CD25(+) regulatory T-cells from human renal transplant recipients.

Alan D. Salama, Mohamed H. Sayegh, Clarkson, 2003 .

Alloreactive T Cell Clone Size Cells, and the + CTLA-4, CD25 Regulating Alloimmunity: Cytokines, Physiological Mechanisms of

Mohamed H. Sayegh, Terry B. Strom, Xin Xiao Zheng, 2010 .

The role of CD25+regulatory cells in restoring tolerance in autoimmune anti-GBM (Goodpasture's) disease.

Alan D. Salama, Mohamed H. Sayegh, Afzal N. Chaudhry, 2002 .

Functions of the PD-1: PD-L1 costimulatory pathway in physiologic regulation of alloimmune responses in vivo

Alan D. Salama, Mohamed H. Sayegh, Hugh Auchincloss, 2003 .

CD70-CD27 is a critical CD28-independent costimulatory pathway for alloimmune CD8+T cell responses

Akira Yamada, John P. Forman, Alan D. Salama, 2003 .

The role of the novel gene, T-bet, in allograft rejection and tolerance.

Alan D. Salama, Mohamed H. Sayegh, Xueli Yuan, 2003 .

Immunomodulation by Mesenchymal Stem Cells

Mohamed H. Sayegh, Mark Atkinson, Reza Abdi, 2008, Diabetes.

Identification of cells initiating human melanomas

Mohamed H. Sayegh, George F. Murphy, T. Kupper, 2008, Nature.

Immunomodulation by Mesenchymal Stem Cells

Mohamed H. Sayegh, Mark Atkinson, Reza Abdi, 2008, Diabetes.